NeoGenomics, Inc. Share Price OTC Bulletin Board
Equities
US64049M2098
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
||
- USD | - |
|
05-28 | NeoGenomics, Inc. to Introduce Comprehensive Lung Solution & Feature Hematopathology Services At ASCO | CI |
05-02 | North American Morning Briefing : Stock Futures -3- | DJ |
Sales 2024 * | 656M 51.32B | Sales 2025 * | 719M 56.3B | Capitalization | 1.75B 137B |
---|---|---|---|---|---|
Net income 2024 * | -72M -5.64B | Net income 2025 * | -47M -3.68B | EV / Sales 2024 * | 3.08 x |
Net Debt 2024 * | 265M 20.76B | Net Debt 2025 * | 238M 18.62B | EV / Sales 2025 * | 2.77 x |
P/E ratio 2024 * |
-24.1
x | P/E ratio 2025 * |
-38
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.75% |
Latest transcript on NeoGenomics, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Chris Smith
CEO | Chief Executive Officer | 61 | 14/08/22 |
Lynn Tetrault
CHM | Chairman | 61 | 11/06/15 |
Jeffrey Sherman
DFI | Director of Finance/CFO | 58 | 06/12/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Kelly
BRD | Director/Board Member | 67 | 14/07/20 |
Chris Smith
CEO | Chief Executive Officer | 61 | 14/08/22 |
David Perez
BRD | Director/Board Member | 63 | 02/11/22 |
1st Jan change | Capi. | |
---|---|---|
-18.64% | 8.32B | |
+70.43% | 4.38B | |
+11.99% | 2.9B | |
-2.10% | 2.65B | |
-58.41% | 1.66B | |
-16.63% | 1.49B | |
+24.33% | 1.28B | |
-50.73% | 999M | |
+17.47% | 967M |